After the funding from BioNTech, AstraZeneca and Oxford University can now also enter the UK market. It is comparatively cheap and more comfortable to cool.
In Great Britain, the way is clear for a second vaccine against the coronavirus. The control authority for drugs and health products let the agent of the manufacturer AstraZeneca and the University of Oxford on the market with emergency approval, as the British government announced.
Great Britain became the first country in the world to give the relatively easy-to-use vaccine the green light. The manufacturers have expressed the hope that the product could become a “vaccine for the world”.
AstraZeneca head Pascal Soriot said the day was necessary for “millions of people in the UK who will have access to this new vaccine”. It is effective, well-tolerated and easy to administer. Also, it is supplied by AstraZeneca without profit. At the beginning of December, the British had already granted emergency approval to the vaccine from the German manufacturer BioNTech and its US partner Pfizer.